Exciting results regarding new possible drug leads for Alzheimer’s
We have had some exciting results regarding new possible drug leads for Alzheimer’s. We hope to be submitting these soon for publication.
Read moreCategory: Timeline
New Protomol (Core B4) core to study enzyme in some kinds of cancer
We’ve been using our new Protomol (Core B4) core to study the activation of src Kinase, an enzyme that is involved in the onset of some kinds of cancer.
Read moreNew software methods for the chaperonin inhibitor project
Del has been involved in the development of new software methods (Ocker) for the chaperonin inhibitor project.
Read moreAlzheimer’s Disease
We presented our results regarding new possible drugs to fight Alzheimer’s Disease at a Stanford University meeting organized by the NIH Roadmap Nanomedicine center.
Read moreViral diseases
During this year we published our first work on some of the molecular interactions that occur during the initial stages of viral infection, and how they can impact current antivirus…
Read moreApplying the drug design methods used in Alzheimer’s to HD
We have also started to apply the drug design methods used in Alzheimer’s to HD.
Read morePresenting the results on HD at a variety of Stanford internal conferences and meetings
Prof. Pande has presented the results on HD at a variety of Stanford internal conferences and meetings. People have been excited and interested in the results.
Read morePresented our results regarding new possible drugs (small molecule leads) to fight Alzheimer’s Disease
We presented our results regarding new possible drugs (small molecule leads) to fight Alzheimer’s Disease at a recent meeting at Stanford, supported by the NIH Roadmap Nanomedicine center and NIH…
Read moreThe first of the papers has come out
The first of the papers has come out (see paper #58 on our Results page: “Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach”). In many…
Read moreDel has presented his plans to the NIH Nanomedicine center
Del has presented his plans to the NIH Nanomedicine center with a very positive response. Planning for the lab side of this work has begun.
Read more